Tsai CH - Search Results

1

Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome.

Chen YZ, Chen ZY, Tang YJ, Tsai CH, Chuang YL, Hsieh EH, Tucker L, Lin IC, Tseng CL. Chen YZ, et al. Among authors: tsai ch. Pharmaceutics. 2021 Oct 27;13(11):1801. doi: 10.3390/pharmaceutics13111801. Pharmaceutics. 2021. PMID: 34834216 Free PMC article.

2

Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye.

Tsai CH, Hoang LN, Lin CC, Pan LC, Wu CL, Lin IC, Wang PY, Tseng CL. Tsai CH, et al. Pharmaceutics. 2022 Jun 13;14(6):1253. doi: 10.3390/pharmaceutics14061253. Pharmaceutics. 2022. PMID: 35745825 Free PMC article.

3

Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.

Tsai CH, Wang PY, Lin IC, Huang H, Liu GS, Tseng CL. Tsai CH, et al. Int J Mol Sci. 2018 Sep 19;19(9):2830. doi: 10.3390/ijms19092830. Int J Mol Sci. 2018. PMID: 30235809 Free PMC article. Review.

4

Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.

Lee WH, Lin CC, Tsai CH, Tien FM, Lo MY, Tseng MH, Kuo YY, Yu SC, Liu MC, Yuan CT, Yang YT, Chuang MK, Ko BS, Tang JL, Sun HI, Chuang YK, Tien HF, Hou HA, Chou WC. Lee WH, et al. Among authors: tsai ch. Blood Cancer J. 2024 Apr 9;14(1):57. doi: 10.1038/s41408-024-01031-9. Blood Cancer J. 2024. PMID: 38594285 Free PMC article.

5

New-onset atrial fibrillation is a red flag to microvascular free tissue transfer failure in head and neck cancer patients.

Tsai CH, Chen YJ, Lin YC, Liu YC, Kao HK, Mao SH. Tsai CH, et al. J Reconstr Microsurg. 2024 Apr 9. doi: 10.1055/a-2302-6992. Online ahead of print. J Reconstr Microsurg. 2024. PMID: 38593991

6

MCP-1 controls IL-17-promoted monocyte migration and M1 polarization in osteoarthritis.

Hsieh SL, Yang SY, Lin CY, He XY, Tsai CH, Fong YC, Lo YS, Tang CH. Hsieh SL, et al. Among authors: tsai ch. Int Immunopharmacol. 2024 Apr 8;132:112016. doi: 10.1016/j.intimp.2024.112016. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38593506

7

Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus.

Chang CP, Yeh TK, Chen CT, Wang WP, Chen YT, Tsai CH, Chen YF, Ke YY, Wang JY, Chen CP, Hsieh TC, Wu MH, Huang CL, Chen YP, Zhuang H, Chi YH. Chang CP, et al. Among authors: tsai ch. Mol Cancer Ther. 2024 Apr 9. doi: 10.1158/1535-7163.MCT-23-0602. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38592383

8

The oldest mysticete in the Northern Hemisphere.

Tsai CH, Goedert JL, Boessenecker RW. Tsai CH, et al. Curr Biol. 2024 Mar 19:S0960-9822(24)00308-7. doi: 10.1016/j.cub.2024.03.011. Online ahead of print. Curr Biol. 2024. PMID: 38552627 Free article.

9

Association Between Leg Muscle Thickness and Walking Test with the Haemophilia-Specific Functional Parameters.

Hong JP, Kang JH, Lee CH, Lee CH, Chen SH, Liu YL, Tsai JR, Tsai CH, Ho WL, Cheng MM, Charoenpong P, Chang CY. Hong JP, et al. Among authors: tsai ch. Am J Phys Med Rehabil. 2024 Mar 26. doi: 10.1097/PHM.0000000000002482. Online ahead of print. Am J Phys Med Rehabil. 2024. PMID: 38547026

10

Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways.

Yu CL, Lai YW, Chen JJ, Lee JJ, Chou TH, Huang CC, Liu SC, Chen GW, Tsai CH, Wang SW. Yu CL, et al. Among authors: tsai ch. J Food Drug Anal. 2023 Dec 15;31(4):696-710. doi: 10.38212/2224-6614.3480. J Food Drug Anal. 2023. PMID: 38526828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,171 results

Search Page